2030 年までのヨーロッパのオピオイド市場予測 - 地域別分析 - 製品別 (即効性短時間作用型オピオイドと徐放性長時間作用型オピオイド)、用途別 (疼痛管理、麻酔、下痢抑制、咳抑制、依存症治療など)、投与経路別 (経口、注射、経皮パッチ)、流通チャネル別 (病院薬局と小売薬局)
慢性疼痛の発生率の急増がヨーロッパのオピオイド市場を牽引
心血管疾患、がん、筋骨格系疾患、神経血管疾患などの慢性疾患は、免疫力を低下させることで人の健康に重大な影響を及ぼします。さらに、これらの症状に苦しむ多くの患者は慢性疼痛を経験しています。上記の疾患は、成人と高齢者に最も多く見られます。しかし、これらの疾患の症例は子供の間でも著しく増加しています。慢性疼痛は、スポーツ選手、アスリート、過去の負傷を抱えて生活している人々にもよく見られます。 NCBI（国立生物工学情報センター）で発表された研究によると、世界中で成人の20％が痛みに悩まされており、10％が毎年新たに慢性疼痛と診断されています。痛みは性別、人種/民族、収入、年齢、または地理的条件に関係なく、すべての人口に影響を及ぼしますが、世界中で均等に分布しているわけではありません。ヒドロコドン、オキシコドン、モルヒネなどの処方オピオイドは、怪我、手術、および癌や関節炎などの健康状態によって引き起こされる痛みの治療に使用される強力な鎮痛薬です。オピオイドの処方慣行の増加は、代替疼痛治療よりもオピオイドを奨励する保険償還プログラム、より効率的なケアを促すコスト構造、および患者満足度と効果的な疼痛管理を組み合わせた評価に起因する可能性があります。したがって、疼痛管理におけるオピオイドの利点により、慢性疾患の患者の間で需要が高まっています。
ヨーロッパのオピオイド市場の概要
ヨーロッパのオピオイド市場は、ドイツ、英国、フランス、イタリア、スペイン、その他のヨーロッパに分かれています。ヨーロッパはヨーロッパのオピオイド市場で重要な位置を占めており、予測期間中に市場が力強く成長すると予想されています。この地域の市場成長は、主に慢性的な痛みを引き起こす病気（関節炎、腰痛、線維筋痛症など）の罹患率の上昇と、オピオイド薬物（ヘロインなど）への依存症を治療するための薬の入手可能性の急増に起因しています。たとえば、メタドンはヨーロッパで最も処方されているオピオイド作動薬であり、オピオイド作動薬維持療法の患者の 75% に使用されています。ブプレノルフィンは、この地域で 2 番目に多く使用されているオピオイド作動薬です。ただし、クロアチア、キプロス、チェコ共和国、フィンランド、フランス、スウェーデンでは、オピオイド維持療法で最も頻繁に使用されているものの 1 つです。コデインはキプロスとドイツで使用されている主要な作動薬ですが、ジアセチルモルヒネはベルギー、デンマーク、ドイツ、オランダ、スペイン、英国、アイルランドで一般的に使用されています。
ヨーロッパのオピオイド市場の収益と2030年までの予測（百万米ドル）
ヨーロッパのオピオイド市場のセグメンテーション
ヨーロッパのオピオイド市場は、製品、用途、投与経路、流通チャネル、国に分類されています。
製品に基づいて、ヨーロッパのオピオイド市場は、即放性短時間作用型オピオイドと徐放性長時間作用型オピオイドに分割されています。即放性短時間作用型オピオイドセグメントは、2022年に大きな市場シェアを占めました。即放性短時間作用型オピオイドは、オキシコドン、ヒドロコドン、トラマドール、コディン、プロポキシフェンなどにさらに細分化されています。徐放性長時間作用型オピオイドは、オキシコドン、フェンタニル、モルヒネ、メタドンなどにさらに細分化されています。
用途別に見ると、欧州のオピオイド市場は、疼痛管理、麻酔、下痢抑制、咳抑制、依存症治療などに分類されています。2022年には疼痛管理セグメントが最大の市場シェアを占めました。
投与経路別に見ると、欧州のオピオイド市場は経口、注射、経皮パッチに分類されています。2022年には経口セグメントが最大の市場シェアを占めました。
流通チャネル別に見ると、欧州のオピオイド市場は病院薬局と小売薬局に分かれています。病院薬局セグメントは、2022年に大きな市場シェアを占めました。
国別に見ると、ヨーロッパのオピオイド市場は、英国、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパに分かれています。2022年には、英国がヨーロッパのオピオイド市場シェアを独占しました。
ヨーロッパのオピオイド市場で事業を展開している大手企業には、Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Hikma Pharmaceuticals Plc、Rusan Pharma Ltd、Teva Pharmaceutical Industries Ltdなどがあります。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Europe Analysis
5.1 Europe Opioids Market Overview
5.2 Europe Opioids Market Revenue (US$ Million), 2020-2030
5.3 Europe Opioids Market Forecast Analysis
6. Europe Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Europe Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Opioids Market - Country Analysis
10.1 Europe
10.1.1 Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 United Kingdom: Europe Opioids Market Breakdown, by Product
10.1.1.2.2 United Kingdom: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 United Kingdom: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.2.4 United Kingdom: Europe Opioids Market Breakdown, by Application
10.1.1.2.5 United Kingdom: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.2.6 United Kingdom: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.3 Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Germany: Europe Opioids Market Breakdown, by Product
10.1.1.3.2 Germany: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 Germany: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.3.4 Germany: Europe Opioids Market Breakdown, by Application
10.1.1.3.5 Germany: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.3.6 Germany: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.4 France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 France: Europe Opioids Market Breakdown, by Product
10.1.1.4.2 France: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 France: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.4.4 France: Europe Opioids Market Breakdown, by Application
10.1.1.4.5 France: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.4.6 France: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.5 Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Italy: Europe Opioids Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 Italy: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.5.4 Italy: Europe Opioids Market Breakdown, by Application
10.1.1.5.5 Italy: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.5.6 Italy: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.6 Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Spain: Europe Opioids Market Breakdown, by Product
10.1.1.6.2 Spain: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.6.3 Spain: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.6.4 Spain: Europe Opioids Market Breakdown, by Application
10.1.1.6.5 Spain: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.6.6 Spain: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.7.1 Rest of Europe: Opioids Market Breakdown, by Product
10.1.1.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.7.4 Rest of Europe: Opioids Market Breakdown, by Application
10.1.1.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
10.1.1.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hikma Pharmaceuticals Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Europe Opioids Market Segmentation
Table 2. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 13. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 25. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 31. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 33. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 35. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 38. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 39. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 40. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 41. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 42. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 43. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 44. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 45. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 46. Recent Organic Growth Strategies in Opioids Market
Table 47. Recent Inorganic Growth Strategies in the Opioids Market
Table 48. Glossary of Terms, Opioids Market
List of Figures
Figure 1. Europe Opioids Market Segmentation, by Country
Figure 2. Europe Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Europe Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Europe Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Europe: Opioids Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)
Figure 23. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Hikma Pharmaceuticals Plc
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe opioids market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe opioids market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.